Northern Trust
OPTR

Northern Trust’s OPTIMER PHARMACEUTICALS, INC. COM STK OPTR Stock Holding History

Northern Trust’s Portfolio OPTR Stock Details OPTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-552,985
Closed -$6.96M – 4191
2013
Q3 		$6.96M Sell
552,985
-151,555
-22% -$2.01M ﹤0.01% 2271
2013
Q2 		$10.2M Buy
+704,540
New +$10.3M ﹤0.01% 1902

Northern Trust's OPTR Position: Q4 2013 in Review

Northern Trust sold out of OPTIMER PHARMACEUTICALS, INC. COM STK (OPTR) in Q4 2013, closing a stake of 552,985 shares — an estimated $6.96M sold.

Northern Trust first reported a position in OPTR in Q2 2013 and held it in 2 quarters. The position peaked at $10.2M in Q2 2013. 0 funds tracked by Wall St. Rank hold OPTR as of Q4 2013.

  • Northern Trust reported no remaining OPTIMER PHARMACEUTICALS, INC. COM STK position as of Q4 2013 after selling out during the quarter.
  • Northern Trust sold 552,985 OPTIMER PHARMACEUTICALS, INC. COM STK shares in Q4 2013, an estimated $6.96M.
  • Northern Trust first reported a position in OPTIMER PHARMACEUTICALS, INC. COM STK in Q2 2013 and held it in 2 quarters.
  • Northern Trust's OPTIMER PHARMACEUTICALS, INC. COM STK position peaked at $10.2M in Q2 2013.
  • 0 funds tracked by Wall St. Rank held OPTIMER PHARMACEUTICALS, INC. COM STK as of Q4 2013.

Based on Northern Trust's 13F filing for Q4 2013, filed 12 Feb 2014.